Published in J Infect Dis on April 15, 2010
Urothelial signaling. Physiol Rev (2013) 2.56
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun (2010) 1.72
Mechanisms of pain from urinary tract infection. Int J Urol (2014) 1.43
Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study. Brain Behav Immun (2015) 0.91
Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathog (2015) 0.90
O-antigen modulates infection-induced pain states. PLoS One (2012) 0.89
Protamine sulfate induced bladder injury protects from distention induced bladder pain. J Urol (2012) 0.89
Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception. Mol Pain (2012) 0.88
Nervous network for lower urinary tract function. Int J Urol (2012) 0.83
The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine. Front Cell Infect Microbiol (2016) 0.81
Animal Models of Urologic Chronic Pelvic Pain Syndromes: Findings From the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network. Urology (2015) 0.80
Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain. PLoS One (2015) 0.79
Stool-based biomarkers of interstitial cystitis/bladder pain syndrome. Sci Rep (2016) 0.78
Immune mediators of chronic pelvic pain syndrome. Nat Rev Urol (2014) 0.78
Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI. PLoS One (2014) 0.77
Uropathogenic E.coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2). PLoS One (2016) 0.76
Uro-science. J Urol (2010) 0.75
Neuroscience: Bacteria get on your nerves. Nature (2013) 0.75
Atypical sensors for direct and rapid neuronal detection of bacterial pathogens. Mol Brain (2016) 0.75
Anger management: bacteria soothe the savage host. J Clin Invest (2013) 0.75
Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1. PLoS One (2016) 0.75
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (1998) 8.16
Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis (2005) 6.85
Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol (2000) 6.68
A toll-like receptor that prevents infection by uropathogenic bacteria. Science (2004) 5.26
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science (1997) 4.57
Induction of vanilloid receptor channel activity by protein kinase C. Nature (2001) 3.95
Selective outgrowth of fimbriate bacteria in static liquid medium. J Bacteriol (1970) 3.69
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A (2005) 3.59
Chaperone-assisted assembly and molecular architecture of adhesive pili. Annu Rev Microbiol (1991) 3.29
Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem (2002) 2.79
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2003) 2.02
Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun (1991) 1.86
Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain (2000) 1.83
Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem (2000) 1.70
Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infect Immun (2001) 1.66
Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. J Dent Res (2006) 1.54
Quantification of bacterial lipopolysaccharides by the purpald assay: measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation. Anal Biochem (1999) 1.46
Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics (2001) 1.42
Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol Microbiol (2001) 1.42
Mast cell-derived histamine mediates cystitis pain. PLoS One (2008) 1.40
Endotoxin-induced local inflammation and hyperalgesia in rats and mice: a new model for inflammatory pain. Pain (1996) 1.40
CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun (2003) 1.38
Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res (1993) 1.37
Organ cross talk modulates pelvic pain. Am J Physiol Regul Integr Comp Physiol (2007) 1.33
Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol (2006) 1.32
Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol (2008) 1.28
Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis (2007) 1.26
Clonal and pathotypic analysis of archetypal Escherichia coli cystitis isolate NU14. J Infect Dis (2001) 1.24
Ambulatory care visits of physician offices, hospital outpatient departments, and emergency departments: United States, 1995. Vital Health Stat 13 (1997) 1.23
Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons. J Neurosci Res (2008) 1.20
Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect Immun (2008) 1.17
Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis (2000) 1.14
Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun (2007) 1.12
Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience (2004) 1.10
Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol (2004) 1.05
Do type 1 fimbriae promote inflammation in the human urinary tract? Cell Microbiol (2007) 1.02
Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res (2002) 1.01
TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell Microbiol (2002) 0.99
SnapShot: Pattern-recognition receptors. Cell (2007) 0.95
The host response to urinary tract infection. Infect Dis Clin North Am (2003) 0.95
Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide. Urol Res (2000) 0.89
Valency conversion in the type 1 fimbrial adhesin of Escherichia coli. Mol Microbiol (2001) 0.86
Asymptomatic bacteriuria in school girls. V. The clinical course and response to treatment. Acta Paediatr Scand (1975) 0.85
Mast cell modulation of the innate immune response to enterobacterial infection. Adv Exp Med Biol (2000) 0.84
Bacterial cystitis is accompanied by increased peripheral thermal sensitivity in mice. J Urol (2007) 0.82
Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. J Physiol (1995) 0.79
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (2011) 12.29
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.70
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
CLINICAL PRACTICE. Urinary Tract Infections in Older Men. N Engl J Med (2016) 2.76
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci U S A (2009) 2.33
Delayed primary closure of bladder exstrophy: immediate postoperative management leading to successful outcomes. Urology (2011) 2.26
Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol (2011) 2.08
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun (2010) 1.72
How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol (2006) 1.68
Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol (2003) 1.66
Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol (2003) 1.62
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55
Th1-Th17 cells contribute to the development of uropathogenic Escherichia coli-induced chronic pelvic pain. PLoS One (2013) 1.53
Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog (2009) 1.53
Molecular effects of genistein on male urethral development. J Urol (2011) 1.51
The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol (2014) 1.47
Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators. J Urol (2010) 1.46
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Pathol (2015) 1.45
Data mining derived treatment algorithms from the electronic medical record improve theoretical empirical therapy for outpatient urinary tract infections. J Urol (2011) 1.44
Prostatitis/chronic pelvic pain syndrome. Annu Rev Med (2006) 1.44
Mechanisms of pain from urinary tract infection. Int J Urol (2014) 1.43
Mast cell-derived histamine mediates cystitis pain. PLoS One (2008) 1.40
Ca(2+)/calmodulin-dependent protein kinase II is associated with pelvic pain of neurogenic cystitis. Am J Physiol Renal Physiol (2012) 1.40
Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol (2008) 1.39
The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate (2008) 1.38
Urinary tract infections in women. Med Clin North Am (2011) 1.34
Organ cross talk modulates pelvic pain. Am J Physiol Regul Integr Comp Physiol (2007) 1.33
Antigen-specific responses accelerate bacterial clearance in the bladder. J Immunol (2006) 1.32
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun (2007) 1.29
Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol (2008) 1.28
Asymptomatic bacteriuria and symptomatic urinary tract infections during pregnancy. Urol Clin North Am (2007) 1.24
Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun (2009) 1.24
Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain (2006) 1.22
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology (2002) 1.21
Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome. Urology (2006) 1.20
Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy. J Urol (2013) 1.17
Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect Immun (2008) 1.17
Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun (2006) 1.15
Angiosarcoma of bladder: long-term survival after multimodal therapy. Urology (2007) 1.12
Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int (2007) 1.10
Role of mast cells in male chronic pelvic pain. J Urol (2012) 1.07
Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha. J Urol (2002) 1.06
Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology (2007) 1.06
Epithelial differentiation promotes the adherence of type 1-piliated Escherichia coli to human vaginal cells. J Infect Dis (2002) 1.06
Tumor necrosis factor promotes differential trafficking of bladder mast cells in neurogenic cystitis. J Urol (2006) 1.02
RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis. Am J Physiol Renal Physiol (2007) 1.01
Urothelial lesion formation is mediated by TNFR1 during neurogenic cystitis. Am J Physiol Renal Physiol (2006) 0.99
CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol (2012) 0.96
A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis (2009) 0.96
Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol (2004) 0.95
Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents (2008) 0.95
Characterization of tight junction proteins in cultured human urothelial cells. In Vitro Cell Dev Biol Anim (2008) 0.95
Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol (2005) 0.93
Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis. BMC Urol (2009) 0.93
Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am (2003) 0.92
Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter. J Biol Chem (2008) 0.91
Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect (2008) 0.90
O-antigen modulates infection-induced pain states. PLoS One (2012) 0.89
Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity. J Urol (2006) 0.89
Induction of the urothelial differentiation program in the absence of stromal cues. J Urol (2005) 0.87
miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome. Am J Pathol (2012) 0.87
Acute and chronic prostatitis. Med Clin North Am (2004) 0.86
PTP1B deficiency exacerbates inflammation and accelerates leukocyte trafficking in vivo. J Immunol (2011) 0.85
Role of bacteria in chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep (2005) 0.84
Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Curr Urol Rep (2008) 0.84
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
The expanding role of fluoroquinolones. Dis Mon (2003) 0.83
Epidemiologic insights into pediatric kidney stone disease. Urol Res (2010) 0.82
Gender specific pelvic pain severity in neurogenic cystitis. J Urol (2011) 0.82
Loss of prostaglandin E2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladders. Am J Physiol Renal Physiol (2008) 0.82
Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. J Biol Chem (2004) 0.82
Is it time to change the training of urology residents in the United States? J Urol (2005) 0.81
Chronic bacterial prostatitis and chronic pelvic pain syndrome. BMJ Clin Evid (2015) 0.81
Long-term results of the bulbourethral sling procedure. J Urol (2005) 0.80